Australia, 23rd Sep 2024, - Neuralia TMS has announced the launch of transcranial magnetic stimulation (TMS) services in Perth, Western Australia. This non-invasive treatment offers new possibilities for patients experiencing treatment-resistant depression and other mental health disorders. With the introduction of TMS, the clinic continues its efforts to provide advanced solutions in mental health care, making this therapy accessible to individuals who may not have benefited from conventional treatments.
TMS is a procedure that uses magnetic fields to stimulate specific areas of the brain involved in mood regulation. The therapy is administered without the need for anaesthesia, allowing patients to receive treatment while remaining conscious and alert. This method has gained recognition for its ability to alleviate symptoms in individuals who have not responded to traditional medications or therapy, providing a new pathway to recovery.
Dr Shanek Wick, Principal Dentist at Neuralia TMS, emphasised the importance of this new service. "The addition of transcranial magnetic stimulation to the treatment options at Neuralia TMS represents a significant development in mental health care for the community. TMS has been demonstrated to improve outcomes for those dealing with persistent depressive disorders, giving patients another avenue to pursue when standard therapies have not been effective."
The service is designed to cater to individuals facing long-term mental health challenges. While primarily aimed at treating major depressive disorders, research indicates that TMS may also benefit patients with anxiety, post-traumatic stress disorder, and other conditions where traditional treatments have failed. The procedure is performed by qualified professionals, ensuring the highest standards of safety and care for each patient undergoing the therapy.
As part of Neuralia TMS’s wider mission, the introduction of TMS services comes at a time when the demand for alternative mental health treatments is rising. The clinic’s commitment to expanding treatment options for residents in Perth reflects its focus on providing evidence-based care that aligns with the latest medical advancements in mental health treatment.
Dr Wick further commented on the potential of TMS to transform mental health services in the region. "This service not only supports those currently struggling with mental health issues but also paves the way for future developments in therapeutic technology. Neuralia TMS remains dedicated to exploring new opportunities in mental health care, and TMS is just one of many innovations anticipate bringing to the community."
The launch of this service adds to the existing range of mental health support services at Neuralia TMS. The clinic remains focused on providing treatments that are both effective and accessible, ensuring that patients receive care that is tailored to their individual needs. TMS is seen as a valuable addition to this portfolio, enhancing the range of tools available to clinicians working with complex cases.
For further information about transcranial magnetic stimulation, Neuralia TMS can be contacted by phone at 08 6230 3996 or via email at info@neuralia.com.au.
Media Contact
Organization: Neuralia TMS
Contact person: Dr Shanek Wick
Website: https://www.neuraliatms.com.au/
Email: info@neuralia.com.au
Contact Number: 61862303996
Country: Australia
Release id: 10092
Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.
